We have developed a novel small animal model of virus induced elastic arteritis that will allow us to define fundamental mechanisms of vascular injury and the role of virus infection and the immune system in controlling or promoting chronic vascular pathology [Nature Medicine, 1997, 3(12):1346-1353]. Little is known about mechanisms that initiate inflammatory lesions of large elastic arteries, and the mechanisms underlying vasculitis are incompletely defined. Recently, attention has been paid to herpesviruses and activated lymphocytes as possible causes or cofactors in vascular injury. Mechanistic studies in a tractable model system have not been performed to determine how herpesvirus infection and the immune system interact to generate or control vascular pathology. We discovered that a newly characterized murine gamma-herpesvirus (gammaHV68) causes striking elastic arteritis in normal mice, and that interferon-gamma (IFNgamma) unresponsive mice and B cell deficient mice are much more susceptible than normal mice to induction of arteritis by gammaHV68. Further analysis revealed (i) a novel tropism of gammaHV68 for vascular smooth muscle cells, (ii) that productive replication is occurring in arteritic lesions, (iii) that IFNgamma acts primarily at the level of somatic cells, and (iv) the pathology of arteritic lesions in IFN-unresponsive and B cell deficient mice are strikingly different. To provide molecular tools for analysis of viral contributions to chronic arteritis we sequenced the genome of gammaHV68 (119,450 bp), demonstrating that gammaHV68 is closely related to the human gamma- herpesviruses Epstein-Barr virus and Kaposi's sarcoma herpesvirus. We have recently isolated mutant and marker rescue gammaHV68, and identified candidate latency-associated gammaHV68 genes. The availability of genetic tools for analysis of the host immune response arid the role of specific viral genes, will allow us to define mechanisms of gammaHV68 induced arteritis as follows.
Aim 1. Determine the contribution of latent and productive gammaHV68 infection to chronic arteritis.
Aim 2. Determine the mechanism by which IFNgamma regulates arteritis.
Aim 3. Determine the mechanism by which B cells regulate arteritis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL060090-02
Application #
6125875
Study Section
Virology Study Section (VR)
Program Officer
Serrate-Sztein, Susana
Project Start
1998-12-15
Project End
2002-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
2
Fiscal Year
2000
Total Cost
$317,201
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Steed, Ashley L; Barton, Erik S; Tibbetts, Scott A et al. (2006) Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 80:192-200
McClellan, Kelly B; Gangappa, Shivaprakash; Speck, Samuel H et al. (2006) Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog 2:e58
Sparks-Thissen, Rebecca L; Braaten, Douglas C; Hildner, Kai et al. (2005) CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma. Virology 338:201-8
Loh, Joy; Chu, Dortha T; O'Guin, Andrew K et al. (2005) Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 79:661-7
Virgin, Herbert W (2005) Immune regulation of viral infection and vice versa. Immunol Res 32:293-315
Barton, Erik S; Lutzke, Mary L; Rochford, Rosemary et al. (2005) Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol 79:14149-60
van Dyk, Linda F; Virgin 4th, Herbert W; Speck, Samuel H (2003) Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol 77:5118-26
Tibbetts, Scott A; McClellan, J Scott; Gangappa, Shivaprakash et al. (2003) Effective vaccination against long-term gammaherpesvirus latency. J Virol 77:2522-9
Moorman, Nathaniel J; Virgin 4th, Herbert W; Speck, Samuel H (2003) Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307:179-90
Pavlova, Iglika V; Virgin 4th, Herbert W; Speck, Samuel H (2003) Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J Virol 77:5731-9

Showing the most recent 10 out of 23 publications